C. Campos

发表

Reversible dimers of the atypical antipsychotic quetiapine inhibit p-glycoprotein-mediated efflux in vitro with increased binding affinity and in situ at the blood-brain barrier.

F. Sharom, C. Hrycyna, J. Chmielewski, 2014, ACS chemical neuroscience.

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain

David S. Miller, B. Hawkins, R. E. Cannon, 2012, Proceedings of the National Academy of Sciences.

PPAR-α, a lipid-sensing transcription factor, regulates blood–brain barrier efflux transporter expression

R. A. Evans, David S. Miller, R. E. Cannon, 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Tight junctions contain oligomeric protein assembly critical for maintaining blood–brain barrier integrity in vivo

M. Seelbach, R. Egleton, T. Davis, 2007, Journal of neurochemistry.

Nicotine increases in vivo blood–brain barrier permeability and alters cerebral microvascular tight junction protein distribution

R. Egleton, T. Abbruscato, J. Huber, 2004, Brain Research.

Blood-brain barrier tight junctions are altered during a 72-h exposure to lambda-carrageenan-induced inflammatory pain.

R. Egleton, J. Huber, T. Davis, 2002, American journal of physiology. Heart and circulatory physiology.

Selective increase of two ABC drug efflux transporters at the blood–spinal cord barrier suggests induced pharmacoresistance in ALS

N. Maragakis, P. Pasinelli, D. Trotti, 2012, Neurobiology of Disease.

Effects of deep hypothermic circulatory arrest on the blood brain barrier in a cardiopulmonary bypass model--a pilot study.

T. Venkatraman, C. Lascola, J. Mathew, 2014, Heart, lung & circulation.

Mrp1 is Essential for Sphingolipid Signaling to P-Glycoprotein in Mouse Blood–Brain and Blood–Spinal Cord Barriers

David S. Miller, R. E. Cannon, C. Campos, 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Effect of lambda-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception.

J. Huber, T. Davis, V. Hau, 2004, Brain research.

Viability of microvascular endothelial cells to direct exposure of formalin, lambda-carrageenan, and complete Freund's adjuvant.

J. Huber, T. Davis, Rachel C Brown, 2002, European journal of pharmacology.

Building a Better Analgesic: Multifunctional Compounds that Address Injury-Induced Pathology to Enhance Analgesic Efficacy while Eliminating Unwanted Side Effects

T. Vanderah, F. Porreca, S. Deekonda, 2013, The Journal of Pharmacology and Experimental Therapeutics.

ABC Transporter Function and Regulation at the Blood–Spinal Cord Barrier

Xueqian Wang, C. Schröter, David S. Miller, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.

C. Hrycyna, J. Chmielewski, D. Davis, 2012, Journal of the American Chemical Society.

Effect of λ-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception

J. Huber, T. Davis, V. Hau, 2004, Brain Research.

Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile.

M. Bentley, R. Egleton, M. J. Roberts, 2003, Journal of pharmaceutical sciences.

Occludin oligomeric assembly at tight junctions of the blood‐brain barrier is disrupted by peripheral inflammatory hyperalgesia

M. Seelbach, T. Davis, G. McCaffrey, 2008, Journal of neurochemistry.

Effect of guanidino modification and proline substitution on the in vitro stability and blood-brain barrier permeability of endomorphin II.

A. Lipkowski, A. Misicka, J. Huber, 2002, Journal of pharmaceutical sciences.

Nociceptive inhibition prevents inflammatory pain induced changes in the blood–brain barrier

R. Egleton, T. Davis, C. Campos, 2008, Brain Research.

Brain Shuttle Neprilysin reduces central Amyloid-β levels

P. Freskgård, J. Niewoehner, E. Urich, 2020, PloS one.

Alterations in blood-brain barrier ICAM-1 expression and brain microglial activation after lambda-carrageenan-induced inflammatory pain.

J. Huber, T. Davis, C. Campos, 2006, American journal of physiology. Heart and circulatory physiology.

Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood–Brain and Blood–Spinal Cord Barriers

Xueqian Wang, Lindsay K. Smith, David S. Miller, 2014, The Journal of Neuroscience.

Central regulation of Blood Brain Barrier integrity during hyperalgesia

C. Campos, 2009 .

Comparative changes in the blood-brain barrier and cerebral infarction of SHR and WKY rats.

Brian T Hawkins, Thomas P Davis, R. Egleton, 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

1α,25‐Dihydroxyvitamin D3‐liganded vitamin D receptor increases expression and transport activity of P‐glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells

R. Bendayan, K. Pang, E. Chow, 2012, Journal of neurochemistry.

ABC Transporter Function and Regulation at the Blood–Spinal Cord Barrier

Xueqian Wang, C. Schröter, David S. Miller, 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

Toward eradicating HIV reservoirs in the brain: inhibiting P-glycoprotein at the blood-brain barrier with prodrug abacavir dimers.

C. Hrycyna, J. Chmielewski, D. Davis, 2012, Journal of the American Chemical Society.